Topical Melatonin for Hair Restoration

Hair RestorationTopical Melatoninbased on 3 studiesLast updated: 2026-04
Every claim on this page traces to a named peer-reviewed study listed in the Research section below.

What is Topical Melatonin for hair loss?

Topical melatonin is melatonin applied directly to the scalp as a solution or serum. Melatonin is produced naturally in hair follicles and is thought to influence the hair growth cycle. Applied topically, it does not significantly affect blood melatonin levels and does not appear to disrupt sleep. No topical melatonin product is FDA-approved for hair loss.

Does Topical Melatonin work for hair loss?

Positive signals exist, but the evidence base is thin and most studies are from one research group. Independent replication in large trials has not been conducted. A 2023 review of 11 human studies found 8 of 11 reported positive outcomes. The only double-blind placebo-controlled RCT (Fischer 2004, 40 women) found a significant increase in the proportion of hairs in the active growth phase at one scalp location. Most other studies are open-label or observational. All 5 studies cited in a 2012 narrative review were conducted by the same group who developed the treatment.

Who it applies to

  • Adults with pattern or diffuse hair loss seeking a low-risk OTC option
  • Most evidence is from women

Who it does not apply to

  • People expecting results comparable to minoxidil or finasteride
  • People with severe pattern hair loss as a primary treatment

What to look for when buying

Every spec brands use in marketing — and what the research actually says.

What brands marketResearch verdictWhat to look for
Concentration 0.1% MattersThe 2023 review identified 0.0033% or 0.1% as the apparent effective range. Most studies used 0.1% applied once daily.
No effect on sleep/circadian rhythm MattersStudies found no significant change in blood melatonin levels from topical application. Sleep disruption is not a concern with scalp application.
Once daily application for 90-180 days MattersThe 2023 review found positive results in studies running 90-180 days of once-daily use.
Independent research⚠️ UnclearMost published studies are from one research group. Independent replication in large trials has not been conducted.
FDA approval Not researchedNo topical melatonin product is FDA-approved for hair loss.

What research cannot tell you

These questions are not answered by any qualified study in our database.

  • Whether topical melatonin works in a large double-blind placebo-controlled trial by an independent research group
  • How it compares to minoxidil
  • Whether it works equally in men and women (only one RCT exists and it enrolled only women)
  • Long-term outcomes beyond the studied periods

Research behind this page

All studies are independent systematic reviews or meta-analyses.

StudyScoreFinding
Topical melatonin in 40 women — the only RCT
4/10
Significant increase in anagen hair proportion at one scalp location vs placebo; 40 women only
Topical melatonin — 5 studies summary
3/10
All 5 studies reported positive effects; all 5 conducted by the same research group
Topical melatonin across 11 human studies
4/10
8 of 11 studies reported positive outcomes; apparent effective dose 0.0033-0.1%; most evidence not from double-blind placebo-controlled trials

What the research says about common buyer questions

Will applying melatonin to my scalp affect my sleep?+

No, based on available evidence. Studies found no significant change in blood melatonin levels from topical scalp application. Sleep disruption is not a documented concern with scalp use.

How should I use it?+

The 2023 review identified 0.0033% or 0.1% concentration applied once daily for 90-180 days as the most studied approach. This is consistent with the concentration and duration used in the positive studies.

Is the research trustworthy?+

The evidence has an important limitation: most published studies were conducted by the same research group who developed the treatment. Independent replication in large trials has not been conducted. The only double-blind placebo-controlled RCT enrolled only 40 women. Positive results are consistent but the absence of independent replication means confidence is limited.